These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 31663114)
1. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy. Tang J; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G J Cell Physiol; 2020 May; 235(5):4746-4755. PubMed ID: 31663114 [TBL] [Abstract][Full Text] [Related]
2. A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients. Tang J; Ren J; Cui Q; Zhang D; Kong D; Liao X; Lu M; Gong Y; Wu G J Cell Mol Med; 2019 Oct; 23(10):6775-6784. PubMed ID: 31429520 [TBL] [Abstract][Full Text] [Related]
3. An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment. Tang J; Cui Q; Zhang D; Liao X; Zhu J; Wu G J Cell Mol Med; 2019 Aug; 23(8):4980-4990. PubMed ID: 31124293 [TBL] [Abstract][Full Text] [Related]
4. A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy. Sun M; Liu X; Xia L; Chen Y; Kuang L; Gu X; Li T Biochem Pharmacol; 2021 Jul; 189():114285. PubMed ID: 33069665 [TBL] [Abstract][Full Text] [Related]
5. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction. Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329 [TBL] [Abstract][Full Text] [Related]
6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
7. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers. Liu D Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968 [TBL] [Abstract][Full Text] [Related]
8. A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen. Wang K; Li J; Xiong YF; Zeng Z; Zhang X; Li HY Sci Rep; 2018 Feb; 8(1):3179. PubMed ID: 29453409 [TBL] [Abstract][Full Text] [Related]
9. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer. Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405 [TBL] [Abstract][Full Text] [Related]
10. A four-long non-coding RNA signature in predicting breast cancer survival. Meng J; Li P; Zhang Q; Yang Z; Fu S J Exp Clin Cancer Res; 2014 Oct; 33(1):84. PubMed ID: 25288503 [TBL] [Abstract][Full Text] [Related]
11. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
12. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
13. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Ma B; Li Y; Ren Y Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer. Ma CX; Bose R; Ellis MJ Adv Exp Med Biol; 2016; 882():125-54. PubMed ID: 26987533 [TBL] [Abstract][Full Text] [Related]
15. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer. Liu YR; Jiang YZ; Xu XE; Hu X; Yu KD; Shao ZM Clin Cancer Res; 2016 Apr; 22(7):1653-62. PubMed ID: 26813360 [TBL] [Abstract][Full Text] [Related]
17. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061 [TBL] [Abstract][Full Text] [Related]
18. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients. Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456 [TBL] [Abstract][Full Text] [Related]
19. Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer. Li J; Wang W; Xia P; Wan L; Zhang L; Yu L; Wang L; Chen X; Xiao Y; Xu C Int J Cancer; 2018 Nov; 143(9):2150-2160. PubMed ID: 29707762 [TBL] [Abstract][Full Text] [Related]
20. A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. Sun J; Chen X; Wang Z; Guo M; Shi H; Wang X; Cheng L; Zhou M Sci Rep; 2015 Nov; 5():16553. PubMed ID: 26549855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]